Noradrenergic antagonism enhances the conditioned aversive effects of cocaine

The propensity to self-administer cocaine may be a function of both its positively reinforcing and aversive effects, with the latter acting as a limiting factor on overall drug taking. However, relative to what is known about the physiological underpinnings of cocaine's positively reinforcing e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacology, biochemistry and behavior biochemistry and behavior, 2008-02, Vol.88 (4), p.523-532
Hauptverfasser: Freeman, Kevin B., Verendeev, Andrey, Riley, Anthony L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 532
container_issue 4
container_start_page 523
container_title Pharmacology, biochemistry and behavior
container_volume 88
creator Freeman, Kevin B.
Verendeev, Andrey
Riley, Anthony L.
description The propensity to self-administer cocaine may be a function of both its positively reinforcing and aversive effects, with the latter acting as a limiting factor on overall drug taking. However, relative to what is known about the physiological underpinnings of cocaine's positively reinforcing effects, little is known about its aversive effects. There is some evidence that cocaine's aversive effects, as indexed in the conditioned taste aversion (CTA) preparation, are catecholaminergically mediated, i.e., through cocaine's actions on the dopaminergic and noradrenergic neurotransmitter systems. Although limited evidence suggests a role for dopamine, there has yet to be a direct assessment of noradrenergic involvement. To better characterize a role for this system, cocaine-induced CTAs (10, 18 and 32 mg/kg) were conducted under conditions of antagonism at the norepinephrine α 1 and β receptors using prazosin (0.3 mg/kg; Experiment 2) and propranolol (10 mg/kg; Experiment 3), respectively, at doses that were determined to be non-aversive (Experiment 1). In each case of noradrenergic antagonism, CTAs with cocaine were not attenuated, suggesting that this drug's conditioned aversive effects are mediated by non-noradrenergic NT activity. Furthermore, prazosin and propranolol administration appeared to facilitate the conditioned aversive effects of cocaine. The implications of these findings in regards to other neurochemical processes are discussed.
doi_str_mv 10.1016/j.pbb.2007.10.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70166544</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305707003231</els_id><sourcerecordid>70166544</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-29f1c9b6aec562969cdb81a79385df78f63d73a8ea5a517f8775e09732b90263</originalsourceid><addsrcrecordid>eNqFkMFOGzEQQK2qqKShH9AL2gu9bfDYu_ZaPVWo0EoULrlbXnsMjhI72JtI_D2OEokbPY1m5s1o5hHyHegCKIjr1WI7jgtGqaz5ggJ8IjMYJG97kPIzmVGqoOW0l-fkaykrSmnHhPxCzmGgXS8km5F_DykblzFifgq2MXEyTymGsmkwPptosTTTMzY2RRemkCK6xuwxl7DHBr1HO5Um-dq3JkS8IGferAt-O8U5Wd7-Xt78ae8f7_7e_LpvbQdsapnyYNUoDNpeMCWUdeMARio-9M7LwQvuJDcDmt7UV_wgZY9USc5GRZngc_LjuHab08sOy6Q3oVhcr03EtCtaVjmi77r_gowKBsBlBeEI2pxKyej1NoeNya8aqD641itdXeuD60Opuq4zl6flu3GD7n3iJLcCVyfAFGvWPlefobxzSikuQVXu55HDqmwfMOtiA1b3LuQqWLsUPjjjDXKQm60</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20621137</pqid></control><display><type>article</type><title>Noradrenergic antagonism enhances the conditioned aversive effects of cocaine</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Freeman, Kevin B. ; Verendeev, Andrey ; Riley, Anthony L.</creator><creatorcontrib>Freeman, Kevin B. ; Verendeev, Andrey ; Riley, Anthony L.</creatorcontrib><description>The propensity to self-administer cocaine may be a function of both its positively reinforcing and aversive effects, with the latter acting as a limiting factor on overall drug taking. However, relative to what is known about the physiological underpinnings of cocaine's positively reinforcing effects, little is known about its aversive effects. There is some evidence that cocaine's aversive effects, as indexed in the conditioned taste aversion (CTA) preparation, are catecholaminergically mediated, i.e., through cocaine's actions on the dopaminergic and noradrenergic neurotransmitter systems. Although limited evidence suggests a role for dopamine, there has yet to be a direct assessment of noradrenergic involvement. To better characterize a role for this system, cocaine-induced CTAs (10, 18 and 32 mg/kg) were conducted under conditions of antagonism at the norepinephrine α 1 and β receptors using prazosin (0.3 mg/kg; Experiment 2) and propranolol (10 mg/kg; Experiment 3), respectively, at doses that were determined to be non-aversive (Experiment 1). In each case of noradrenergic antagonism, CTAs with cocaine were not attenuated, suggesting that this drug's conditioned aversive effects are mediated by non-noradrenergic NT activity. Furthermore, prazosin and propranolol administration appeared to facilitate the conditioned aversive effects of cocaine. The implications of these findings in regards to other neurochemical processes are discussed.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/j.pbb.2007.10.011</identifier><identifier>PMID: 18045672</identifier><identifier>CODEN: PBBHAU</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adrenergic alpha-Antagonists - pharmacology ; Adrenergic beta-Antagonists - pharmacology ; Animals ; Avoidance Learning - drug effects ; Biological and medical sciences ; Cocaine ; Cocaine - pharmacology ; Conditioned taste aversion ; Conditioning, Operant - drug effects ; Dopamine Uptake Inhibitors - pharmacology ; Dose-Response Relationship, Drug ; Male ; Medical sciences ; Neuropharmacology ; Norepinephrine ; Norepinephrine - antagonists &amp; inhibitors ; Pharmacology. Drug treatments ; Prazosin ; Prazosin - pharmacology ; Propanolol ; Propranolol - pharmacology ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Rats, Sprague-Dawley ; Sympathetic Nervous System - drug effects ; Taste - drug effects</subject><ispartof>Pharmacology, biochemistry and behavior, 2008-02, Vol.88 (4), p.523-532</ispartof><rights>2007 Elsevier Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-29f1c9b6aec562969cdb81a79385df78f63d73a8ea5a517f8775e09732b90263</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091305707003231$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19993719$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18045672$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Freeman, Kevin B.</creatorcontrib><creatorcontrib>Verendeev, Andrey</creatorcontrib><creatorcontrib>Riley, Anthony L.</creatorcontrib><title>Noradrenergic antagonism enhances the conditioned aversive effects of cocaine</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>The propensity to self-administer cocaine may be a function of both its positively reinforcing and aversive effects, with the latter acting as a limiting factor on overall drug taking. However, relative to what is known about the physiological underpinnings of cocaine's positively reinforcing effects, little is known about its aversive effects. There is some evidence that cocaine's aversive effects, as indexed in the conditioned taste aversion (CTA) preparation, are catecholaminergically mediated, i.e., through cocaine's actions on the dopaminergic and noradrenergic neurotransmitter systems. Although limited evidence suggests a role for dopamine, there has yet to be a direct assessment of noradrenergic involvement. To better characterize a role for this system, cocaine-induced CTAs (10, 18 and 32 mg/kg) were conducted under conditions of antagonism at the norepinephrine α 1 and β receptors using prazosin (0.3 mg/kg; Experiment 2) and propranolol (10 mg/kg; Experiment 3), respectively, at doses that were determined to be non-aversive (Experiment 1). In each case of noradrenergic antagonism, CTAs with cocaine were not attenuated, suggesting that this drug's conditioned aversive effects are mediated by non-noradrenergic NT activity. Furthermore, prazosin and propranolol administration appeared to facilitate the conditioned aversive effects of cocaine. The implications of these findings in regards to other neurochemical processes are discussed.</description><subject>Adrenergic alpha-Antagonists - pharmacology</subject><subject>Adrenergic beta-Antagonists - pharmacology</subject><subject>Animals</subject><subject>Avoidance Learning - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cocaine</subject><subject>Cocaine - pharmacology</subject><subject>Conditioned taste aversion</subject><subject>Conditioning, Operant - drug effects</subject><subject>Dopamine Uptake Inhibitors - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Norepinephrine</subject><subject>Norepinephrine - antagonists &amp; inhibitors</subject><subject>Pharmacology. Drug treatments</subject><subject>Prazosin</subject><subject>Prazosin - pharmacology</subject><subject>Propanolol</subject><subject>Propranolol - pharmacology</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Taste - drug effects</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFOGzEQQK2qqKShH9AL2gu9bfDYu_ZaPVWo0EoULrlbXnsMjhI72JtI_D2OEokbPY1m5s1o5hHyHegCKIjr1WI7jgtGqaz5ggJ8IjMYJG97kPIzmVGqoOW0l-fkaykrSmnHhPxCzmGgXS8km5F_DykblzFifgq2MXEyTymGsmkwPptosTTTMzY2RRemkCK6xuwxl7DHBr1HO5Um-dq3JkS8IGferAt-O8U5Wd7-Xt78ae8f7_7e_LpvbQdsapnyYNUoDNpeMCWUdeMARio-9M7LwQvuJDcDmt7UV_wgZY9USc5GRZngc_LjuHab08sOy6Q3oVhcr03EtCtaVjmi77r_gowKBsBlBeEI2pxKyej1NoeNya8aqD641itdXeuD60Opuq4zl6flu3GD7n3iJLcCVyfAFGvWPlefobxzSikuQVXu55HDqmwfMOtiA1b3LuQqWLsUPjjjDXKQm60</recordid><startdate>20080201</startdate><enddate>20080201</enddate><creator>Freeman, Kevin B.</creator><creator>Verendeev, Andrey</creator><creator>Riley, Anthony L.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20080201</creationdate><title>Noradrenergic antagonism enhances the conditioned aversive effects of cocaine</title><author>Freeman, Kevin B. ; Verendeev, Andrey ; Riley, Anthony L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-29f1c9b6aec562969cdb81a79385df78f63d73a8ea5a517f8775e09732b90263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adrenergic alpha-Antagonists - pharmacology</topic><topic>Adrenergic beta-Antagonists - pharmacology</topic><topic>Animals</topic><topic>Avoidance Learning - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cocaine</topic><topic>Cocaine - pharmacology</topic><topic>Conditioned taste aversion</topic><topic>Conditioning, Operant - drug effects</topic><topic>Dopamine Uptake Inhibitors - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Norepinephrine</topic><topic>Norepinephrine - antagonists &amp; inhibitors</topic><topic>Pharmacology. Drug treatments</topic><topic>Prazosin</topic><topic>Prazosin - pharmacology</topic><topic>Propanolol</topic><topic>Propranolol - pharmacology</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Taste - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Freeman, Kevin B.</creatorcontrib><creatorcontrib>Verendeev, Andrey</creatorcontrib><creatorcontrib>Riley, Anthony L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Freeman, Kevin B.</au><au>Verendeev, Andrey</au><au>Riley, Anthony L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Noradrenergic antagonism enhances the conditioned aversive effects of cocaine</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>2008-02-01</date><risdate>2008</risdate><volume>88</volume><issue>4</issue><spage>523</spage><epage>532</epage><pages>523-532</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><coden>PBBHAU</coden><abstract>The propensity to self-administer cocaine may be a function of both its positively reinforcing and aversive effects, with the latter acting as a limiting factor on overall drug taking. However, relative to what is known about the physiological underpinnings of cocaine's positively reinforcing effects, little is known about its aversive effects. There is some evidence that cocaine's aversive effects, as indexed in the conditioned taste aversion (CTA) preparation, are catecholaminergically mediated, i.e., through cocaine's actions on the dopaminergic and noradrenergic neurotransmitter systems. Although limited evidence suggests a role for dopamine, there has yet to be a direct assessment of noradrenergic involvement. To better characterize a role for this system, cocaine-induced CTAs (10, 18 and 32 mg/kg) were conducted under conditions of antagonism at the norepinephrine α 1 and β receptors using prazosin (0.3 mg/kg; Experiment 2) and propranolol (10 mg/kg; Experiment 3), respectively, at doses that were determined to be non-aversive (Experiment 1). In each case of noradrenergic antagonism, CTAs with cocaine were not attenuated, suggesting that this drug's conditioned aversive effects are mediated by non-noradrenergic NT activity. Furthermore, prazosin and propranolol administration appeared to facilitate the conditioned aversive effects of cocaine. The implications of these findings in regards to other neurochemical processes are discussed.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>18045672</pmid><doi>10.1016/j.pbb.2007.10.011</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-3057
ispartof Pharmacology, biochemistry and behavior, 2008-02, Vol.88 (4), p.523-532
issn 0091-3057
1873-5177
language eng
recordid cdi_proquest_miscellaneous_70166544
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adrenergic alpha-Antagonists - pharmacology
Adrenergic beta-Antagonists - pharmacology
Animals
Avoidance Learning - drug effects
Biological and medical sciences
Cocaine
Cocaine - pharmacology
Conditioned taste aversion
Conditioning, Operant - drug effects
Dopamine Uptake Inhibitors - pharmacology
Dose-Response Relationship, Drug
Male
Medical sciences
Neuropharmacology
Norepinephrine
Norepinephrine - antagonists & inhibitors
Pharmacology. Drug treatments
Prazosin
Prazosin - pharmacology
Propanolol
Propranolol - pharmacology
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Rats
Rats, Sprague-Dawley
Sympathetic Nervous System - drug effects
Taste - drug effects
title Noradrenergic antagonism enhances the conditioned aversive effects of cocaine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A37%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Noradrenergic%20antagonism%20enhances%20the%20conditioned%20aversive%20effects%20of%20cocaine&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Freeman,%20Kevin%20B.&rft.date=2008-02-01&rft.volume=88&rft.issue=4&rft.spage=523&rft.epage=532&rft.pages=523-532&rft.issn=0091-3057&rft.eissn=1873-5177&rft.coden=PBBHAU&rft_id=info:doi/10.1016/j.pbb.2007.10.011&rft_dat=%3Cproquest_cross%3E70166544%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20621137&rft_id=info:pmid/18045672&rft_els_id=S0091305707003231&rfr_iscdi=true